ATEA PHARMACEUTICALS, INC.
Ownership & governance
Executives 5Directors 9Avg age 64Avg tenure 7.3y
JS
Jean-Pierre Sommadossi
Chief Executive Officer
Age 70Since 2012-11-30Profile →
+13
Executives5
JS
Jean-Pierre Sommadossi→
Chief Executive Officer
Age 70Since 2012-11-30
AC
Andrea Corcoran
Director of Finance/CFO
Age 63Since 2020-09-30
AD
Adam DeZure
Chief Tech/Sci/R&D Officer
——
MH
Maria Horga
Chief Tech/Sci/R&D Officer
Age 57Since 2020-09-30
JB
Jonae Barnes
Investor Relations Contact
—Since 2021-01-18
Board of directors9
JS
Jean-Pierre Sommadossi→
Chairman
Age 70Since 2012-11-30
PM
Polly Murphy→
Director/Board Member
Age 61Since 2020-07-31
FB
Franklin Berger→
Director/Board Member
Age 76Since 2019-08-31
BL
Bruno Lucidi→
Director/Board Member
Age 66Since 2014-08-31
BP
Bruce Polsky→
Director/Board Member
Age 72Since 2014-10-31
BD
Barbara Duncan→
Director/Board Member
Age 61Since 2020-09-30
JA
Jerome Adams→
Director/Board Member
Age 51Since 2021-05-19
AK
Arthur Kirsch→
Director/Board Member
Age 74Since 2025-02-19
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Fidelity Management & Research Co. LLC | 14.93 % | 11,950,772 |
| BlackRock Advisors LLC | 9.964 % | 7,973,989 |
| BML Capital Management LLC | 8.82 % | 7,058,657 |
| Jean-Pierre Sommadossi | 8.29 % | 6,633,855 |
| Tang Capital Management LLC | 6.016 % | 4,814,700 |
Catalog · 2026-07-09
Proxy officers16
| Name | Role | Since | Shares |
|---|---|---|---|
| Jean-Pierre Sommadossi | Chairman | 2012-11-30 | - |
| Arthur Kirsch | Director or executive officer | 2025-01-01 | 118,954 |
| Arthur Kirsch | Director/Board Member | 2025-02-19 | - |
| Barbara Duncan | Director or executive officer | 2020-01-01 | 396,789 |
| Barbara Duncan | Director/Board Member | 2020-09-30 | - |
| Bruce Polsky | Director/Board Member | 2014-10-31 | - |
| Bruce Polsky, MD, MACP, FIDSA | Director or executive officer | 2014-01-01 | 554,245 |
| Bruno Lucidi | Director/Board Member | 2014-08-31 | - |
Proxy · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 9.42Range 7–11.25Analysts 3
7Mean 9.4211.25
- Buy 2
- Hold 1
Broker actions26
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Morgan Stanley | Maintained | Equal-Weight | 7 | 2026-08-13 |
| Evercore ISI Group | Maintained | Outperform | 10 | 2026-03-09 |
| Morgan Stanley | Maintained | Equal-Weight | 6 | 2025-04-11 |
| Morgan Stanley | Upgrade | Equal-Weight | 6.88 | 2024-08-13 |
| JP Morgan | Downgrade | Underweight | — | 2023-08-10 |
| JP Morgan | Maintained | Neutral | 8 | 2023-03-16 |
| SVB Leerink | Maintained | Market Perform | 6 | 2023-01-27 |
| Morgan Stanley | Maintained | Underweight | 4 | 2023-01-24 |
| Morgan Stanley | Maintained | Underweight | 7 | 2022-08-15 |
| JP Morgan | Maintained | Neutral | 8 | 2022-03-02 |
| SVB Leerink | Maintained | Market Perform | 9 | 2022-03-01 |
| SVB Leerink | Maintained | Market Perform | 10 | 2022-02-16 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.